Effect of Physician Attire on Patients' Preference of Physician

November 11, 2020 updated by: M.D. Anderson Cancer Center

Advanced Cancer Patients' Perception of Physician Compassion and Professionalism - A Randomized, Double Blind, Cross Over Trial

The goal of this research study is to learn about the effects of a doctor's characteristics on participant's preference for a doctor. Researchers also want to learn about how a doctor's characteristics affect participant's options about professionalism and compassion.

Study Overview

Detailed Description

If participant agrees to take part in this study, participant will be asked to complete 7 questionnaires. These questionnaires ask about participant's gender, date of birth, ethnicity, marital status, level of education, religion, and information about the disease and treatments participant received. Participant will also be asked about any symptoms participant may be having, how much trust participant has in the medical profession in general, how participant feels about the disease, any depression or anxiety participant may have, and participant's level of hopefulness. These questionnaires should take about 6 minutes to complete.

Participant will be shown 2 videos (each 3 minutes long) and then participant will complete questions about each video. Participant will be asked to rate the doctors participant saw on their professionalism and their compassion.

Caregivers will be required to leave the room or stay silent while the participant is watching the videos.

The total time to watch the videos and complete the second set of questionnaires should be about 7 minutes.

Finally, participant will be asked to complete 3 questionnaires about participant's overall preference for a doctor. These questionnaires will take about 5 minutes to complete.

Length of Study Participation:

Participation in this study is complete after participant answers the final questionnaires.

Overall, this study should take about 30 minutes to complete.

This is an investigational study.

Up to 108 participants will be enrolled in this study. All will take part at MD Anderson.

Study Type

Interventional

Enrollment (Actual)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • University of Texas MD Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Advanced cancer diagnosis (locally advanced, recurrent or metastatic disease).
  2. Patients presenting as follow-ups only at the outpatient Supportive Care Center.
  3. Age >/= 18 years-old
  4. English speaking

Exclusion Criteria:

  1. Altered cognition (as assessed routinely in the Supportive Care Clinic using the Memorial Delirium Assessment Scale (MDAS), with a score of >/= 7/30).
  2. Patients suffering from a severe psychiatric disorder or condition that would significantly interfere with study participation.
  3. Patients with hearing and/or visual impairments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Video 1A

Questionnaires completed at baseline, after each video viewing, and at completion.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.
Questionnaires completed at baseline, after each video viewing, and at completion.
Other Names:
  • Surveys
Experimental: Video 1B

Questionnaires completed at baseline, after each video viewing, and at completion.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.
Questionnaires completed at baseline, after each video viewing, and at completion.
Other Names:
  • Surveys
Experimental: Video 2A

Questionnaires completed at baseline, after each video viewing, and at completion.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.
Questionnaires completed at baseline, after each video viewing, and at completion.
Other Names:
  • Surveys
Experimental: Video 2B

Questionnaires completed at baseline, after each video viewing, and at completion.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.
Questionnaires completed at baseline, after each video viewing, and at completion.
Other Names:
  • Surveys

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant's Perception of Physician's Compassion
Time Frame: 1 day

Participant's rating of physician's compassion assessed by using a validated 5-item tool consisting of five 0-10 numerical rating scales assessing five dimensions: warm-cold, pleasant-unpleasant, compassionate- distant, sensitive- insensitive, and caring-uncaring.

The sum of the five scales gives a final score representing physician's compassion on a scale of 0 to 50.

1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant's Perception of Physician's Professionalism
Time Frame: 1 day

Participant's rating of physician's professionalism assessed by using a validated 4-item tool assessing politeness, listening, explaining the condition and treatment to the patient and patient's involvement in treatment decisions. Participant rates from poor-1 to very good-5.

The sum of these 4 items gives a final score representing physician's level of professionalism on a scale of 4 to 20.

1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ahsan Azhar, MD, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2017

Primary Completion (Actual)

October 26, 2020

Study Completion (Actual)

October 26, 2020

Study Registration Dates

First Submitted

May 25, 2017

First Submitted That Met QC Criteria

May 25, 2017

First Posted (Actual)

May 30, 2017

Study Record Updates

Last Update Posted (Actual)

November 13, 2020

Last Update Submitted That Met QC Criteria

November 11, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2016-0970
  • NCI-2018-01195 (Registry Identifier: NCI CTRP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malignant Neoplasms of Independent (Primary) Multiple Sites

Clinical Trials on Video

3
Subscribe